Baltimore City Health Commissioner Commends Maryland General Assembly for Passing Legislation to Stop Prescription Drug Gouging

FOR IMMEDIATE RELEASE

Media Contacts:

Michelle Mendes: Office: (410) 396-7286, Cell: (443) 862-0891

BALTIMORE, MD (April 10, 2017) — Today, Baltimore City Health Commissioner Dr. Leana Wen issued the following statement in response to the Maryland General Assembly’s passage of House Bill 631, which will authorize the State’s Attorney General's Office to take legal action to stop price gouging of off-patent or generic drugs:

“We applaud the Maryland General Assembly for passing landmark legislation that will help to keep prescription medications affordable for families across the state. If signed into law, Maryland would be the first state in the country to take such a stance on prescription price gouging.

“As an emergency physician, I have seen patients who have had to make the impossible choice between buying critical medications and paying for rent or food. Some of these patients have had to pay with their lives because of the inability to afford treatment.

“Price gouging is inhuman and unconscionable, especially as Maryland — and the rest of the nation — continues to an epidemic of opioid overdose deaths. This is particularly tragic because there is one medication, naloxone, that can completely reverse an opioid overdose. In Baltimore alone, residents have used naloxone to save 800 lives over the past two years.

“Unfortunately, the price of naloxone has more than doubled, meaning that those of us on the frontlines have to make difficult decisions about to whom we distribute naloxone—and who may or may not be able to live. This makes no sense, as naloxone is a generic medication available for pennies in other countries. No one should be priced out of the ability to save a life.

“House Bill 631 will allow the State’s Attorney General’s Office to pursue civil litigation and penalties, such as fines, for companies that excessively raise the price of generic drugs. Ensuring that life-saving and life-enhancing prescription drugs remain accessible and affordable is key to promoting the health, wellness and security of families and communities.

“This legislation marks a significant step in making health care more affordable for Maryland families and continues our state’s tradition of being on the forefront of improving health and wellness. We thank the sponsors for supporting this important legislation, and encourage the Governor’s swift signature to make House Bill 631 into law.”

Related Stories

Baltimore City Officials Urge Residents to Safely Dispose of Unused Prescription Drugs

During National Prescription Drug Take-Back Day, residents can deposit medications at ten permanent return boxes across the city

BALTIMORE, MD (April 28, 2017) –  On Saturday, April 29th, Baltimore City officials will recognize National Prescription Drug Take Back Day, a nationwide initiative to highlight safe, convenient, and responsible means of disposing of prescription drugs in communities, while raising awareness about prescription drug addiction.

Baltimore City Health Department Recognizes National Infant Immunization Week

BALTIMORE, MD (April 24, 2017)This week, the Baltimore City Health Department recognizes National Infant Immunization Week (April 22-29, 2017) in an effort to raise awareness about the importance of vaccinating infants and young children to protect them from harmful and contagious diseases.

Baltimore City Health Commissioner Honored by University of Iowa College of Public Health with Hansen Award

BALTIMORE, MD (April 19, 2017) — Today, Baltimore City Health Commissioner Dr. Leana Wen was named the recipient of the Richard and Barbara Hansen Leadership Award and Distinguished Lectureship by the University of Iowa College of Public Health. Dr. Wen was selected as this year’s awardee in recognition of her leadership in improving well-being and reducing health disparities.